20044 studies found for:    ( NOT NOTEXT ) [FIRST-RECEIVED-RESULTS-DATE]
Show Display Options
Rank Status Study
21 Completed
Has Results
Purge Vs no Purge in Living Donor Liver Transplantation Recipients
Condition: Ischemia Reperfusion Injury
Intervention: Other: Purge of graft contents out of the circulation
22 Completed
Has Results
Observational Study of MIRCERA in Users of Self-Application and Multidose Systems
Condition: Renal Anemia of Chronic Kidney Disease
Intervention: Device: MIRCERA
23 Completed
Has Results
An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant
Condition: Anemia, Kidney Transplantation
Intervention: Drug: Methoxy-polyethyleneglycol epoetin beta
24 Completed
Has Results
Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
Condition: Follicular Lymphoma
Intervention: Drug: Rituximab
25 Active, not recruiting
Has Results
Clinical Outcome Study for the Triathlon Cruciate Retaining (CR) Total Knee
Condition: Total Knee Arthroplasty
Intervention: Device: Triathlon CR Total Knee System
26 Completed
Has Results
Effect of a Multi-directional Power Toothbrush on Recession
Condition: Gingival Recession
Interventions: Device: Toothbrushing with manual toothbrush;   Device: Toothbrushing with power toothbrush
27 Active, not recruiting
Has Results
Stryker Triathlon Total Knee System for Total Knee Arthroplasty Implanted Using ShapeMatch® Cutting Guides: Sub-Study B
Condition: Arthroplasties, Replacement, Knee
Intervention: Device: ShapeMatch Cutting Guides with Triathlon
28 Active, not recruiting
Has Results
A Trial of Mechanical Axis vs Kinematic Alignment in Total Knee Replacement
Conditions: Arthroplasties;   Knee Replacement
Interventions: Device: OtisMed® ShapeMatch® Technology;   Device: Stryker Precision Knee Navigation;   Procedure: Total Knee Replacement;   Device: Stryker Triathlon® Total Knee System
29 Completed
Has Results
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors
Condition: Neoplasms, Advanced Solid
Interventions: Drug: Trebananib 3 mg/kg;   Drug: Trebananib 10 mg/kg;   Drug: Trebananib 30 mg/kg
30 Completed
Has Results
Stryker Triathlon Total Knee System for Total Knee Arthroplasty Implanted Using Shapematch Cutting Guides:Sub-Study A
Condition: Arthroplasties, Replacement, Knee
Intervention: Device: Shapematch Cutting Guides
31 Completed
Has Results
An Observational Study of Peginterferon Alfa-2a Plus Ribavirin for Hepatitis C Virus (HCV) Infection in Austria
Condition: Hepatitis C
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin
32 Completed
Has Results
Comparison of Outcomes Between Parenteral and Enteral Nutrition
Condition: Deglutition Disorders
Interventions: Device: Parenteral nutrition;   Device: Enteral nutrition
33 Completed
Has Results
An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab
Condition: Rheumatoid Arthritis
Intervention:
34 Completed
Has Results
A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Erlotinib;   Drug: Pertuzumab
35 Completed
Has Results
Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Drug: Xenical, Pionorm, Diroton, Diltiazem, Atorvastatin;   Dietary Supplement: "Analimentary detoxication"
36 Active, not recruiting
Has Results
SYNERGY China: Assess SYNERGY Stent in China
Condition: Cardiovascular Diseases
Intervention: Device: SYNERGYTM Coronary Stent System
37 Completed
Has Results
Effect of Tetanus on Neuromuscular Junction Monitor Performance in Pediatric Patients
Condition: Muscle Relaxation
Intervention: Procedure: Tetanus
38 Completed
Has Results
A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors
Condition: Solid Tumor
Interventions: Drug: Capecitabine;   Drug: RhuMab 2C4
39 Completed
Has Results
A Study of Pertuzumab in Participants With Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Pertuzumab
40 Completed
Has Results
A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors
Condition: Solid Tumor
Interventions: Drug: Docetaxel;   Drug: RhuMab 2C4

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years